NCT02855086 2020-03-31Cetuximab-IRDye 800CW in Detecting Tumors in Patients With Malignant Glioma Undergoing SurgeryStanford UniversityPhase 1/2 Terminated3 enrolled 7 charts
NCT00265928 2008-01-28Bortezomib and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's LymphomaNational Cancer Institute (NCI)Phase 2 Terminated46 enrolled